Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2020-08-04 2020-08-04
Drug Identification Number 02049481 02049481
Brand name NOVAHISTEX DH NOVAHISTEX DH
Common or Proper name Novahistex DH Novahistex DH
Company Name SANOFI-AVENTIS CANADA INC SANOFI-AVENTIS CANADA INC
Ingredients PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE
Strength(s) 20MG 5MG 20MG 5MG
Dosage form(s) SYRUP SYRUP
Route of administration ORAL ORAL
Packaging size 100ml 100ml
ATC code R05DA R05DA
ATC description COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-03-31 2020-03-31
Actual discontinuation date 2020-04-09 2020-04-09
Remaining supply date 2020-03-31 2020-03-31
Discontinuation status Discontinued Discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments last lot 8131851 expiry 2022-05-29 last lot 8131851 expiry 2022-05-29
Health Canada comments